Is the combined use of insulin resistance indices, Including adipokines, more reliable in metabolic syndrome?

MakaleAçık Erişim
  • SDG 3 · Sağlık ve Kaliteli Yaşam

Özet

Background/aim: To determine the levels of adipokines (leptin, adiponectin, resistin, and visfatin) and the indices of insulin sensitivity/ resistance, and to examine the relationship among them in patients with metabolic syndrome (MetS).; Materials and methods: The study groups included 45 subjects with MetS (31 women/14 men), and 45 sex- and age-matched non-MetS healthy volunteers (31 women/14 men). The levels of adipokines were determined by enzyme-linked immunosorbent assay.; Results: The levels of leptin and visfatin were significantly higher in the MetS than in the non-MetS subjects (P < 0.01). There was no difference in adiponectin levels in subjects with and without MetS (P = 0.052). Similarly, resistin did not show any statistically significant difference. A statistically significant positive correlation of leptin with insulin levels was observed, while negative correlations of visfatin levels with age, and resistin levels with the ratio of adiponectin to leptin, were found in the MetS (P < 0.05). The combination of adipokines, insulin resistance-sensitivity parameters, and MetS criteria parameters gave more signifcant differences than a single parameter.; Conclusion: Since the parameters mentioned above might affect, interact with, and/or interfere with each other, the combinations of these parameters might give more reliable results to evaluate the insulin resistance/sensitivity in MetS patients.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/gumushane/15782Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.3906/sag-1310-90Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorKural, Birgül
dc.contributor.authorDeğer, Orhan
dc.contributor.authorErem, Cihangir
dc.contributor.authorBalaban Yücesan, Fulya
dc.contributor.authorAliyazicioğlu, Rezzan
dc.contributor.authorBarlak, Yaşam
dc.date.accessioned2026-10-22T10:24:31.982459179Z
dc.date.available2026-10-22T10:24:31.982459179Z
dc.date.issued2014
dc.description.abstractBackground/aim: To determine the levels of adipokines (leptin, adiponectin, resistin, and visfatin) and the indices of insulin sensitivity/ resistance, and to examine the relationship among them in patients with metabolic syndrome (MetS).; Materials and methods: The study groups included 45 subjects with MetS (31 women/14 men), and 45 sex- and age-matched non-MetS healthy volunteers (31 women/14 men). The levels of adipokines were determined by enzyme-linked immunosorbent assay.; Results: The levels of leptin and visfatin were significantly higher in the MetS than in the non-MetS subjects (P < 0.01). There was no difference in adiponectin levels in subjects with and without MetS (P = 0.052). Similarly, resistin did not show any statistically significant difference. A statistically significant positive correlation of leptin with insulin levels was observed, while negative correlations of visfatin levels with age, and resistin levels with the ratio of adiponectin to leptin, were found in the MetS (P < 0.05). The combination of adipokines, insulin resistance-sensitivity parameters, and MetS criteria parameters gave more signifcant differences than a single parameter.; Conclusion: Since the parameters mentioned above might affect, interact with, and/or interfere with each other, the combinations of these parameters might give more reliable results to evaluate the insulin resistance/sensitivity in MetS patients.
dc.description.sponsorshipKaradeniz Technical University Research Fund [2003.114.003.5, 2006.114.001.2]
dc.identifier.doi10.3906/sag-1310-90
dc.identifier.eissn1303-6165
dc.identifier.endpage1028
dc.identifier.issn1300-0144
dc.identifier.issue6
dc.identifier.pmid25552156
dc.identifier.scopus2-s2.0-84908079347
dc.identifier.startpage1021
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/gumushane/15782
dc.identifier.volume44
dc.identifier.wosWOS:000344155900017
dc.language.isoen
dc.publisherTurkiye Klinikleri Journal of Medical Sciences
dc.relation.ispartofTurkish Journal of Medical Sciences
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAdiponectin
dc.subjectinsulin resistance
dc.subjectleptin
dc.subjectmetabolic syndrome
dc.subjectresistin
dc.subjectvisfatin
dc.subject.classificationMedicine, General & Internal
dc.subject.classificationGeneral & Internal Medicine
dc.subject.otherAdipokines
dc.subject.otherAdiponectin
dc.subject.otherAdult
dc.subject.otherHomeostasis
dc.subject.otherHumans
dc.subject.otherInsulin Resistance
dc.subject.otherLeptin
dc.subject.otherMale
dc.subject.otherMetabolic Syndrome X
dc.subject.otherMiddle Aged
dc.subject.otherNicotinamide Phosphoribosyltransferase
dc.subject.otheradipocytokine
dc.subject.otherglucose
dc.subject.otherhigh density lipoprotein cholesterol
dc.subject.otherinsulin
dc.subject.otherresistin
dc.subject.othertriacylglycerol
dc.subject.otherabdominal obesity
dc.subject.otherArticle
dc.subject.otherclinical article
dc.subject.othercontrolled study
dc.subject.otherenzyme linked immunosorbent assay
dc.subject.otherfemale
dc.subject.otherhuman
dc.subject.otherhypertension
dc.subject.otherhypertriglyceridemia
dc.subject.otheriliac crest
dc.subject.otherinsulin sensitivity
dc.subject.othermean arterial pressure
dc.subject.otherwaist circumference
dc.subject.otherblood
dc.subject.otherpathophysiology
dc.subject.otherphysiology
dc.titleIs the combined use of insulin resistance indices, Including adipokines, more reliable in metabolic syndrome?
dc.typeArticle
dspace.entity.typePublication
rdl.citation.openalex8
rdl.citation.scopus7
rdl.citation.trdizin0
rdl.citation.wos7
rdl.oa.statusgreen
rdl.oa.statusclosed
rdl.oa.urlhttps://hdl.handle.net/20.500.12440/4295
rdl.sdgSDG03
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexTRDIZIN
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)